134
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Protein-losing enteropathy and joint contractures caused by a novel homozygous ANTXR2 mutation

, , , , &
Pages 17-21 | Published online: 27 Jun 2018

References

  • Shin HT, Paller A, Hoganson G, Willner JP, Chang MW, Orlow SJ. Infantile systemic hyalinosis. J Am Acad Dermatol. 2004;50(Suppl 2):S61–S64.
  • Shieh JTC, Hoyme HE, Arbour LT. Hyalinosis, inherited systemic. In: Pagon RA, Adam MP, Ardinger HH, et al, editors. GeneReviews®. Seattle: University of Washington; 1993.
  • El-Kamah GY, Fong K, El-Ruby M, et al. Spectrum of mutations in the ANTXR2 (CMG2) gene in infantile systemic hyalinosis and juvenile hyaline fibromatosis. Br J Dermatol. 2010;163(1):213–215.
  • Dowling O, Difeo A, Ramirez MC, et al. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet. 2003;73(4):957–966.
  • Denadai R, Bertola DR, Stelini RF, Raposo-Amaral CE. Additional thoughts about juvenile hyaline fibromatosis and infantile systemic hyalinosis. Adv Anat Pathol. 2012;19(3):191–192.
  • Denadai R, Raposo-Amaral CE, Bertola D, et al. Identification of 2 novel ANTXR2 mutations in patients with hyaline fibromatosis syndrome and proposal of a modified grading system. Am J Med Genet A. 2012;158A(4):732–742.
  • Deuquet J, Lausch E, Superti-Furga A, van der Goot FG. The dark sides of capillary morphogenesis gene 2. EMBO J. 2012;31(1):3–13.
  • Al Sinani S, Al Murshedy F, Abdwani R. Infantile systemic hyalinosis: a case report with a novel mutation. Oman Med J. 2013;28(1):53–55.
  • Deuquet J, Lausch E, Guex N, et al. Hyaline fibromatosis syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors. EMBO Mol Med. 2011;3(4):208–221.
  • Fong K, Rama Devi AR, Lai-Cheong JE, et al. Infantile systemic hyalinosis associated with a putative splice-site mutation in the ANTXR2 gene. Clin Exp Dermatol. 2012;37(6):635–638.
  • Hanks S, Adams S, Douglas J, et al. Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet. 2003;73(4):791–800.
  • Jaouad IC, Guaoua S, Hajjioui A, Sefiani A. Hyaline fibromatosis syndrome with mutation c.1074delT of the CMG2 gene: a case report. J Med Case Rep. 2014;8:291.
  • Tanaka K, Ebihara T, Kusubata M, et al. Abnormal collagen deposition in fibromas from patient with juvenile hyaline fibromatosis. J Dermatol Sci. 2009;55(3):197–200.
  • Tumer L, Kasapkara C, Fong K, Serdaroglu A, McGrath JA. Hyaline fibromatosis syndrome resulting from a new homozygous missense mutation, p.Gly116Val, in ANTXR2. J Dermatol. 2013;40(8):677–678.
  • Wang YY, Wen CQ, Wei Z, Jin X. A novel splice site mutation in ANTXR2 (CMG2) gene results in systemic hyalinosis. J Pediatr Hematol Oncol. 2011;33(8):e355–e357.
  • Lek M, Karczewski K, Minikel EV, et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–291.
  • Shieh JT, Swidler P, Martignetti JA, et al. Systemic hyalinosis: a distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2). Pediatrics. 2006;118(5):e1485–e1492.
  • Liu S, Crown D, Miller-Randolph S, et al. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A. 2009;106(30):12424–12429.
  • Bell SE, Mavila A, Salazar R, et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci. 2001;114(Pt 15):2755–2773.
  • Yan SE, Lemmin T, Salvi S, et al. In-depth analysis of hyaline fibromatosis syndrome frameshift mutations at the same site reveal the necessity of personalized therapy. Hum Mutat. 2013;34(7):1005–1017.